Current environment: Medicare part D looms, ongoing fallout from Vioxx

Article Abstract:

The federal government is taking up various initiatives to tackle the issue of government aid to Medicare. Part of this, is the prescription drug benefit, often referred to as PDP or Part D. This has provided ample opportunities to pharmaceutical industries, who perceive good sales for their drugs in the near future. The controversies surrounding drug safety of COX0-2 inhibitors, such as MerckEs Vioxx, the various steps taken by the Food and Drug Administration in this regard, and the strategies pharmaceutical companies are taking to maintain their sales, are also discussed.

Government expenditures, Forecasts, trends, outlooks, Sales & consumption, All Other Miscellaneous Ambulatory Health Care Services, Drugs Reimbursement Benefits, Disease Testing Programs, Drugs, Product defects and recalls, COX-2 inhibitors, Prescription drug plans, United States. Food and Drug Administration, Drug evaluation, Industry sales and revenue, Government finance, Industry forecasts

---

GSK to post summaries of trial results online

Article Abstract:

GlaxoSmithKline (GSK) has decided to provide the results of all its clinical trials on its website while Merck & Co has supported the concept of providing late stage clinical trials results mostly the Phase III and Phase IV on the website hosted by the government registry on clinical trials. The demand made by the American Medical Association (AMA) to the United States government to establish a public registry for providing clinical trials results conducted by companies has been discussed.

Sweden, Science & research, Management dynamics, Standards, Research, Management, American Medical Association, Company business management, United States. Department of Health and Human Services, Disclosure of information, GlaxoSmithKline AB

---

How the industry operates

Article Abstract:

An analysis on the different types of healthcare services; role of government with respect to Medicaid, Medicare, cost based reimbursement for hospitals; the different legislations introduced for individuals as well as for the industry; and the important role played by managed care organizations which includes the health maintenance organizations (HMOs) and the preferred provider organization (PPO), are discussed.

Medicaid, Administration of Public Health Programs, Medical Service and Health Insurance, Health care industry, Health insurance industry

Similar abstracts:

• Abstracts: How the industry operates. Current environment: managed care continues to profit. Congress passes Medicare Rx
• Abstracts: aaiPharma finally restates results. Managed care posts healthy profits. Financial analysis

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.